RE: Hibiscus24 Jul 2020 13:40
I think Solidarity and Remap have made CALIBRE redundant, at least for now.
With Covid numbers still so high in the States now would be the ideal time to start HIBISCUS, so that leaves the question is it funding arrangements or regulatory approval that are causing the delay?
The FDA accepted the design and protocol for CALIBER (as per RNS 9/3/20) so can we assume its funding?
If it is funding I for one am wondering if Markku is holding off signing an agreement giving away to much of Traumakine until we get some answers back from Solidarity which could have the potential to transform the way Traumakine is valued.
As it seems we are currently not having to fund CALIBER, and the cost of the WHO trials is only the supply of the drugs I would have liked to have seen us press ahead and fund HIBISCUS ourselves, if SNG can recruit for and run a trial in such a short time frame surly we could have done the same...but what do I know.